logo oncology-news

Онкология  >  Новости онкологии

При финансовой поддержке logo MSD Oncology

Trastuzumab deruxtecan gets FDA nod for HER2+ unresectable or metastatic breast cancer

This antibody-drug conjugate has a high response rate, but a boxed warning for interstitial lung disease.